Emergent BioSolutions (EBS) Receivables - Other (2017 - 2025)
Historic Receivables - Other for Emergent BioSolutions (EBS) over the last 9 years, with Q3 2025 value amounting to $19.3 million.
- Emergent BioSolutions' Receivables - Other rose 52.08% to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.3 million, marking a year-over-year increase of 52.08%. This contributed to the annual value of $19.6 million for FY2024, which is 6186.77% down from last year.
- Emergent BioSolutions' Receivables - Other amounted to $19.3 million in Q3 2025, which was up 52.08% from $22.9 million recorded in Q2 2025.
- In the past 5 years, Emergent BioSolutions' Receivables - Other registered a high of $82.5 million during Q2 2024, and its lowest value of $19.2 million during Q3 2024.
- Moreover, its 5-year median value for Receivables - Other was $51.6 million (2021), whereas its average is $48.0 million.
- Its Receivables - Other has fluctuated over the past 5 years, first surged by 9136.21% in 2021, then plummeted by 7224.24% in 2025.
- Quarter analysis of 5 years shows Emergent BioSolutions' Receivables - Other stood at $51.6 million in 2021, then rose by 10.85% to $57.2 million in 2022, then fell by 10.14% to $51.4 million in 2023, then tumbled by 61.87% to $19.6 million in 2024, then decreased by 1.53% to $19.3 million in 2025.
- Its Receivables - Other stands at $19.3 million for Q3 2025, versus $22.9 million for Q2 2025 and $30.9 million for Q1 2025.